In this COBRE, novel approaches to developing chemical probes and therapeutic leads will be pursued by a diverse team of scientists. This COBRE will create new libraries for high-throughput screening, provide new perspectives on innate immune response and neurodegenerative disease, enable new screening technology, and advance the state of the art in virtual screening. The proposed COBRE will build a network of scientific collaboration throughout the UD campus through five subprojects: 1. Development of an Immunostimulatory Small Molecule Library 2. In vitro neural disease models for high throughput drug screening 3. New Synthetic Methods for Diverse Small Molecule Library Preparation 4. Electrochemical Chemiluminescent Arrays and Emitters for Rapid Chemical Probe Identification 5. Realizing the predictive promise of high throughput virtual screening The proposed COBRE will establish a regional network of biomedical collaboration between scientists at UD and the Nemours Center for Childhood Cancer Research. In a rich collaboration across all five subprojects, UD researchers will interface extensively with scientists from the NCI Molecular Targets Laboratory (MTL) and Chemical Biology Laboratories (CBL), with interactions that include mentorship by NCI scientists, crosstraining experiences for graduate students at NCI, and collaborative mechanisms for follow-up on promising discoveries. With new core instrumentation and facilities, this COBRE will increase the infrastructure for biomedical research at UD. The scope of the center will be further expanded through faculty recruitment and seed grants, and via explicit mechanisms that will facilitate both biological and chemical follow-up on initial discoveries. This COBRE will also establish a mentoring network that will support the career development of assistant faculty, and place them on an accelerated path toward independent funding.
The medicinal field is currently limited by the ability to discover new classes of molecules that can probe and treat human disease. The proposed work will have impact on discovery of molecules that can be used to study and treat a number of diseases, including cancer, Crohn's disease, Huntington's disease, Alzheimer's disease, and Creutzfeldt-Jakob disease.
|Zhou, Qi; Cobb, Kelsey M; Tan, Tianyu et al. (2016) Stereospecific Cross Couplings To Set Benzylic, All-Carbon Quaternary Stereocenters in High Enantiopurity. J Am Chem Soc 138:12057-60|
|Fash, David M; Peer, Cody J; Li, Zhenwu et al. (2016) Synthesis of a stable and orally bioavailable englerin analogue. Bioorg Med Chem Lett 26:2641-4|
|Mori-Quiroz, Luis M; Shimkin, Kirk W; Rezazadeh, Sina et al. (2016) Copper-Catalyzed Amidation of Primary and Secondary Alkyl Boronic Esters. Chemistry 22:15654-15658|
|Basch, Corey H; Cobb, Kelsey M; Watson, Mary P (2016) Nickel-Catalyzed Borylation of Benzylic Ammonium Salts: Stereospecific Synthesis of Enantioenriched Benzylic Boronates. Org Lett 18:136-9|
|DeAngelis, Andrew; Panish, Robert; Fox, Joseph M (2016) Rh-Catalyzed Intermolecular Reactions of Î±-Alkyl-Î±-Diazo Carbonyl Compounds with Selectivity over Î²-Hydride Migration. Acc Chem Res 49:115-27|
|Lyman, Edward; Sodt, Alexander J (2016) Amphipathic Helices-Wedge? Or Nae Nae? Biophys J 110:1-2|
|Zhou, Qi; Srinivas, Harathi D; Zhang, Songnan et al. (2016) Accessing Both Retention and Inversion Pathways in Stereospecific, Nickel-Catalyzed Miyaura Borylations of Allylic Pivalates. J Am Chem Soc 138:11989-95|
|Sodt, A J; Venable, R M; Lyman, E et al. (2016) Nonadditive Compositional Curvature Energetics of Lipid Bilayers. Phys Rev Lett 117:138104|
|Rehmann, Matthew S; Luna, Jesus I; Maverakis, Emanual et al. (2016) Tuning microenvironment modulus and biochemical composition promotes human mesenchymal stem cell tenogenic differentiation. J Biomed Mater Res A 104:1162-74|
|Panish, Robert A; Chintala, Srinivasa R; Fox, Joseph M (2016) A Mixed-Ligand Chiral Rhodium(II) Catalyst Enables the Enantioselective Total Synthesis of Piperarborenineâ€…B. Angew Chem Int Ed Engl 55:4983-7|
Showing the most recent 10 out of 29 publications